NCT00972855View on ClinicalTrials.gov

Study of Bicalutamide 1 x 50 mg Tablet in Healthy Subjects Under Fed Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

September 30, 2003

Primary Completion Date

September 30, 2003

Study Completion Date

September 30, 2003

Conditions
Healthy
Interventions
DRUG

Bicalutamide

50 mg Tablet

DRUG

Casodex®

50 mg Tablet

Trial Locations (1)

G1V 2K8

Anapharm Inc., Sainte-Foy

All Listed Sponsors
lead

Teva Pharmaceuticals USA

INDUSTRY

NCT00972855 - Study of Bicalutamide 1 x 50 mg Tablet in Healthy Subjects Under Fed Conditions | Biotech Hunter | Biotech Hunter